Quick Answer
LEMAITRE VASCULAR INC reported Net Income Loss of $57.73 million for the year ending 2025.
- LEMAITRE VASCULAR INC showed an increase of +31.1% in Net Income Loss from 2024 to 2025.
- This data is from LEMAITRE VASCULAR INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), LEMAITRE VASCULAR INC's Net Income Loss has grown by 3,512.9%.
- Historical annual values: Fiscal year 2025: $57.73 million | Fiscal year 2024: $44.04 million | Fiscal year 2023: $30.11 million | Fiscal year 2022: $20.64 million | Fiscal year 2021: $26.91 million | Fiscal year 2020: $21.22 million | Fiscal year 2019: $17.93 million | Fiscal year 2018: $22.94 million | Fiscal year 2017: $17.18 million | Fiscal year 2016: $10.59 million | Fiscal year 2015: $7.76 million | Fiscal year 2014: $3.92 million | Fiscal year 2013: $3.20 million | Fiscal year 2012: $2.57 million | Fiscal year 2011: $2.14 million | Fiscal year 2010: $6.01 million | Fiscal year 2009: $1.60 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: